ARTICLE | Clinical News
ALX-0141: Completed Phase I enrollment
September 13, 2010 7:00 AM UTC
Ablynx disclosed in its 1H10 interim report that it completed enrollment of 42 healthy postmenopausal women in a double-blind, placebo-controlled Phase I trial evaluating a single subcutaneous injecti...